Searching News Database: Orexo
HSMN NewsFeed - 2 Jul 2020
Orexo Launches Deprexis(R) and Vorvida(R) in the US and Provides Updated Financial Guidance
Orexo Launches Deprexis(R) and Vorvida(R) in the US and Provides Updated Financial Guidance
HSMN NewsFeed - 1 Oct 2018
Orexo Internalizes Contract Field Force in the US to Further Strengthen the Commercial Organization
Orexo Internalizes Contract Field Force in the US to Further Strengthen the Commercial Organization
HSMN NewsFeed - 6 Oct 2016
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
HSMN NewsFeed - 5 Jul 2013
U.S. FDA Approves Zubsolv(R) for the Maintenance Treatment of Opioid Dependence
U.S. FDA Approves Zubsolv(R) for the Maintenance Treatment of Opioid Dependence
HSMN NewsFeed - 14 Jan 2011
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
Orexo and Invida Jointly Announce Agreement for Abstral(TM) in Asia Pacific
HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
HSMN NewsFeed - 16 Mar 2009
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
HSMN NewsFeed - 31 Jul 2008
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
Orexo and ProStrakan Extend Licensing Agreement for Rapinyl/Abstral and change Partner in North America
HSMN NewsFeed - 17 Dec 2007
Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
Endo Announces Positive Results From Interim Analysis of RAPINYL(TM) Phase III Clinical Trial
HSMN NewsFeed - 23 Nov 2007
Orexo Completes the Acquisition of Biolipox, Appoints New CEO and Publishes a Prospectus
Orexo Completes the Acquisition of Biolipox, Appoints New CEO and Publishes a Prospectus
HSMN NewsFeed - 25 Oct 2007
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
Orexo Signs Distribution Agreement with Hospira in Asia for Pain Product Rapinyl(TM)
HSMN NewsFeed - 1 Aug 2007
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Orexo Establishes Sales Force in Nordic Markets, by Entering into a Joint Venture with ProStrakan
Additional items found! 2
Members Archive contains
2 additional stories matching:
Orexo
(Password required)
Orexo
(Password required)